Objective: to evaluate the value of six immunohistochemical markers for distinguish malignant pleural mesothelioma from pleural adenocarcinoma. Material and method: From January 2008 to December 2010, we have included in a prospective monocentric protocol 94 successive patients who were anatomopathologically diagnosed as malignant pleural mesothelioma and pleural carcinomas.